Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythemia and acute leukemia

D Ferrari1, G Ticozzelli, M De Vizzi

  • 1Divisione di Medicina Interna, Ospedale C. Cantù, Abbiategrasso, Milano, Italia.

Haematologica
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Driving under the influence of drugs: An overview of current legal frameworks.

Forensic science review·2025
Same author

Open vs. laparoscopic vs. robotic pouch excision: unveiling the best approach for optimal outcomes.

Techniques in coloproctology·2024
Same author

Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene.

Stem cell research·2024
Same author

Assessing robotic-assisted surgery versus open approach in penetrating Crohn's disease: advantages and outcomes in ileocolic resection.

Techniques in coloproctology·2024
Same author

Effects of Fitlight training on cognitive-motor performance in élite judo athletes.

Heliyon·2024
Same author

Robotic resection of presacral tumors.

Techniques in coloproctology·2024

Essential thrombocythemia (ET) can transform into acute myeloid leukemia (AML) rapidly. This case highlights a fatal outcome despite treatment, emphasizing the aggressive nature of leukemic evolution in myeloproliferative neoplasms.

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
  • Leukemic transformation is a rare but serious complication of ET.
  • Understanding the risk factors and clinical course of leukemic evolution is crucial for patient management.

Observation:

  • A patient diagnosed with essential thrombocythemia (ET) experienced leukemic evolution.
  • The transformation to acute myeloid leukemia (AML) occurred six months post-diagnosis.
  • The patient was undergoing treatment with hydroxyurea (HU) at the time of transformation.

Findings:

  • The patient rapidly developed acute myeloid leukemia (AML) while on hydroxyurea (HU) therapy.
  • Despite prompt treatment with low-dose cytarabine (ARA-C), the patient's condition deteriorated swiftly.

Related Experiment Videos

  • The patient succumbed to the disease within four days of AML diagnosis.

    • Implications:

    • This case underscores the potential for rapid leukemic transformation in ET, even with standard therapy.
    • It highlights the aggressive nature of acute myeloid leukemia (AML) arising from essential thrombocythemia (ET).
    • Further research into predicting and preventing leukemic transformation in ET is warranted.